GUARDANT HEALTH INC (GH) Fundamental Analysis & Valuation

NASDAQ:GH • US40131M1099

Current stock price

91.155 USD
+1.5 (+1.67%)
Last:

This GH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. GH Profitability Analysis

1.1 Basic Checks

  • GH had negative earnings in the past year.
  • In the past year GH has reported a negative cash flow from operations.
  • In the past 5 years GH always reported negative net income.
  • In the past 5 years GH always reported negative operating cash flow.
GH Yearly Net Income VS EBIT VS OCF VS FCFGH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200M -400M -600M

1.2 Ratios

  • GH's Return On Assets of -20.67% is on the low side compared to the rest of the industry. GH is outperformed by 79.00% of its industry peers.
Industry RankSector Rank
ROA -20.67%
ROE N/A
ROIC N/A
ROA(3y)-25.63%
ROA(5y)-27.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GH Yearly ROA, ROE, ROICGH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K

1.3 Margins

  • GH has a Gross Margin of 64.46%. This is amongst the best in the industry. GH outperforms 84.00% of its industry peers.
  • GH's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for GH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.47%
GM growth 5Y-0.99%
GH Yearly Profit, Operating, Gross MarginsGH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. GH Health Analysis

2.1 Basic Checks

  • GH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • GH has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, GH has more shares outstanding
  • Compared to 1 year ago, GH has an improved debt to assets ratio.
GH Yearly Shares OutstandingGH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
GH Yearly Total Debt VS Total AssetsGH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • GH has an Altman-Z score of 1.72. This is a bad value and indicates that GH is not financially healthy and even has some risk of bankruptcy.
  • GH has a Altman-Z score (1.72) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.72
ROIC/WACCN/A
WACC8.15%
GH Yearly LT Debt VS Equity VS FCFGH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • GH has a Current Ratio of 4.84. This indicates that GH is financially healthy and has no problem in meeting its short term obligations.
  • GH has a Current ratio of 4.84. This is amongst the best in the industry. GH outperforms 92.00% of its industry peers.
  • A Quick Ratio of 4.56 indicates that GH has no problem at all paying its short term obligations.
  • GH has a better Quick ratio (4.56) than 92.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.84
Quick Ratio 4.56
GH Yearly Current Assets VS Current LiabilitesGH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. GH Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 5.62% over the past year.
  • GH shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.88%.
  • The Revenue has been growing by 27.92% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)5.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.11%
Revenue 1Y (TTM)32.88%
Revenue growth 3Y29.76%
Revenue growth 5Y27.92%
Sales Q2Q%39.37%

3.2 Future

  • The Earnings Per Share is expected to grow by 26.17% on average over the next years. This is a very strong growth
  • GH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.92% yearly.
EPS Next Y17.14%
EPS Next 2Y20.22%
EPS Next 3Y24.13%
EPS Next 5Y26.17%
Revenue Next Year30.9%
Revenue Next 2Y29.54%
Revenue Next 3Y28.48%
Revenue Next 5Y26.92%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
GH Yearly Revenue VS EstimatesGH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B 4B
GH Yearly EPS VS EstimatesGH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5

More info and screens

Find the best growth stocksShow best growing peers

1

4. GH Valuation Analysis

4.1 Price/Earnings Ratio

  • GH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year GH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GH Price Earnings VS Forward Price EarningsGH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GH Per share dataGH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • GH's earnings are expected to grow with 24.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.22%
EPS Next 3Y24.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GH Dividend Analysis

5.1 Amount

  • No dividends for GH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GH Fundamentals: All Metrics, Ratios and Statistics

GUARDANT HEALTH INC

NASDAQ:GH (4/7/2026, 12:48:42 PM)

91.155

+1.5 (+1.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-19
Earnings (Next)04-30
Inst Owners100.86%
Inst Owner Change0%
Ins Owners3.99%
Ins Owner Change-0.25%
Market Cap11.96B
Revenue(TTM)982.02M
Net Income(TTM)-416.28M
Analysts85.88
Price Target132.26 (45.09%)
Short Float %9.11%
Short Ratio5.83
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.41%
Min EPS beat(2)-38.56%
Max EPS beat(2)-2.26%
EPS beat(4)0
Avg EPS beat(4)-10.51%
Min EPS beat(4)-38.56%
Max EPS beat(4)-0.34%
EPS beat(8)0
Avg EPS beat(8)-11.47%
EPS beat(12)4
Avg EPS beat(12)0.71%
EPS beat(16)6
Avg EPS beat(16)-0.16%
Revenue beat(2)2
Avg Revenue beat(2)5%
Min Revenue beat(2)0.76%
Max Revenue beat(2)9.24%
Revenue beat(4)4
Avg Revenue beat(4)5.15%
Min Revenue beat(4)0.76%
Max Revenue beat(4)9.24%
Revenue beat(8)8
Avg Revenue beat(8)5.73%
Revenue beat(12)12
Avg Revenue beat(12)4.71%
Revenue beat(16)13
Avg Revenue beat(16)3.19%
PT rev (1m)0.34%
PT rev (3m)21.18%
EPS NQ rev (1m)-0.95%
EPS NQ rev (3m)-17.83%
EPS NY rev (1m)-11.03%
EPS NY rev (3m)-16.5%
Revenue NQ rev (1m)0.16%
Revenue NQ rev (3m)2.94%
Revenue NY rev (1m)2.75%
Revenue NY rev (3m)3.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.18
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.36
EYN/A
EPS(NY)-2.78
Fwd EYN/A
FCF(TTM)-1.78
FCFYN/A
OCF(TTM)-1.41
OCFYN/A
SpS7.49
BVpS-0.76
TBVpS-1.54
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.67%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.46%
FCFM N/A
ROA(3y)-25.63%
ROA(5y)-27.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.47%
GM growth 5Y-0.99%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 121.57%
Cap/Sales 4.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.84
Quick Ratio 4.56
Altman-Z 1.72
F-Score5
WACC8.15%
ROIC/WACCN/A
Cap/Depr(3y)84.04%
Cap/Depr(5y)160.9%
Cap/Sales(3y)4.43%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.11%
EPS Next Y17.14%
EPS Next 2Y20.22%
EPS Next 3Y24.13%
EPS Next 5Y26.17%
Revenue 1Y (TTM)32.88%
Revenue growth 3Y29.76%
Revenue growth 5Y27.92%
Sales Q2Q%39.37%
Revenue Next Year30.9%
Revenue Next 2Y29.54%
Revenue Next 3Y28.48%
Revenue Next 5Y26.92%
EBIT growth 1Y1.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year52.61%
EBIT Next 3Y33.25%
EBIT Next 5Y29.86%
FCF growth 1Y15.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.97%
OCF growth 3YN/A
OCF growth 5YN/A

GUARDANT HEALTH INC / GH Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GUARDANT HEALTH INC (GH) stock?

ChartMill assigns a fundamental rating of 3 / 10 to GH.


Can you provide the valuation status for GUARDANT HEALTH INC?

ChartMill assigns a valuation rating of 1 / 10 to GUARDANT HEALTH INC (GH). This can be considered as Overvalued.


Can you provide the profitability details for GUARDANT HEALTH INC?

GUARDANT HEALTH INC (GH) has a profitability rating of 1 / 10.